GDF15
Growth/differentiation factor 15
Also known as: GDF15_HUMAN, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99988
- Gene
- GDF15
- Ensembl
- ENSG00000130513
- Chromosome
- 19
- Canonical length
- 308 aa
- Protein class
- Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. The protein is expressed in a broad range of cell types, acts as a pleiotropic cytokine and is involved in the stress response program of cells after cellular injury. Increased protein levels are associated with disease states such as tissue hypoxia, inflammation, acute injury and oxidative stress. [provided by RefSeq, Aug 2016]
Canonical amino-acid sequenceUniProt
308 residues, UniProt reviewed canonical sequence.
>Q99988|GDF15
1 MPGQELRTVN GSQMLLVLLV LSWLPHGGAL SLAEASRASF PGPSELHSED SRFRELRKRY
61 EDLLTRLRAN QSWEDSNTDL VPAPAVRILT PEVRLGSGGH LHLRISRAAL PEGLPEASRL
121 HRALFRLSPT ASRSWDVTRP LRRQLSLARP QAPALHLRLS PPPSQSDQLL AESSSARPQL
181 ELHLRPQAAR GRRRARARNG DHCPLGPGRC CRLHTVRASL EDLGWADWVL SPREVQVTMC
241 IGACPSQFRA ANMHAQIKTS LHRLKPDTVP APCCVPASYN PMVLIQKTDT GVSLQTYDDL
301 LAKDCHCILocalizationUniProt · AlphaFold · HPA
Whether an antibody against GDF15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 328 nTPM
Expression across tissuesHPA
Tissue
- kidney: 328 nTPM
- urinary bladder: 148 nTPM
- choroid plexus: 123 nTPM
- pancreas: 113 nTPM
- prostate: 97 nTPM
- liver: 88 nTPM
Single-cell type
- syncytiotrophoblasts: 6,139 nCPM
- pancreatic acinar cells: 2,931 nCPM
- urothelial cells: 2,097 nCPM
- prostatic hillock cells: 1,218 nCPM
- prostatic club cells: 1,045 nCPM
- pancreatic duct cells: 766 nCPM
Immune cell
- neutrophil: 2.5 nTPM
- non-classical monocyte: 1.1 nTPM
- eosinophil: 1 nTPM
- classical monocyte: 0.7 nTPM
- intermediate monocyte: 0.6 nTPM
- myeloid DC: 0.4 nTPM
Brain region
- choroid plexus: 72 nTPM
- hippocampal formation: 7.9 nTPM
- thalamus: 3.6 nTPM
- cerebral cortex: 3.1 nTPM
- medulla oblongata: 2.6 nTPM
- midbrain: 2.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GDF15.
Disease | AllUniProt
Conditions GDF15 is implicated in, by any mechanism.
- Hyperemesis gravidarum (HG) MIM:620730
ReferencesPubMed · IEDB
Publications for GDF15 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Evidence of a new antigen-antibody system (anti-Mic-1) in patients with systemic lupus erythematosus and hyperthyroidism.
1989 · J Rheumatol · RCR 0.3 · 4 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.87
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.29
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor protein serine/threonine kinase signaling pathway
- cell-cell signaling
- cellular response to chemical stress
- GDF15-GFRAL signaling pathway
- negative regulation of appetite
- negative regulation of growth hormone receptor signaling pathway
- negative regulation of leukocyte migration
- negative regulation of multicellular organism growth
- negative regulation of SMAD protein signal transduction
- negative regulation of transforming growth factor beta receptor signaling pathway
- positive regulation of fatty acid oxidation
- positive regulation of MAPK cascade
- positive regulation of myoblast fusion
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- reduction of food intake in response to dietary excess
- response to metformin
- signal transduction
- transforming growth factor beta receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GDF15 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GDF15 as an antibody target. Whether an autoantibody or antibody against GDF15 could matter depends on whether native GDF15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GDF15 is annotated as secreted, so native GDF15 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label GDF15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...